E10.610
Type 1 diabetes mellitus with diabetic neuropathic arthropathy
Clinical Classification Guidelines
Inclusion Terms
- Type 1 diabetes mellitus with Charcôt's joints
Medical Intelligence & Overview
Type 1 diabetes mellitus is a chronic condition characterized by the pancreas producing little or no insulin. When it becomes complicated by diabetic neuropathic arthropathy, also called Charcot's joints, it involves the progressive destruction of a joint due to nerve damage. This condition can severely impact mobility and quality of life. Recognized under ICD-10 code E10.610, this combination necessitates a comprehensive understanding to manage effectively.
Causes & Symptoms
Clinical Causes: Insufficient insulin production from the pancreas leading to high blood sugar levels. Prolonged uncontrolled diabetes resulting in nerve damage (diabetic neuropathy). Nerve damage weakening joint support, making joints susceptible to injury and degeneration. Repeated minor injuries or unnoticed trauma due to sensory loss, leading to joint destruction. Chronic inflammation and deterioration of joint tissue owing to neuropathy.
Key Symptoms: Swelling in the affected joint, often in the foot or ankle. Redness and warmth over the joint area. Deformity or abnormal shape of the joint or limb. Loss of sensation or numbness around the joint. Difficulty moving or weight-bearing on the affected limb. Progressive joint instability and potential collapse if untreated.
Diagnostic & Treatment
Diagnosis Path: Diagnosing diabetic neuropathic arthropathy involves a combination of medical history, physical examination, and diagnostic tests. Health professionals may perform:
Treatment Protocols: Managing this condition aims to control blood sugar levels and prevent further joint damage. Approaches include:
Clinical Advice & FAQs
Billing Guidance
Is E10.610 a billable ICD-10 code?
Yes, E10.610 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E10.610?
Clinical documentation must specify the nature of Type 1 diabetes mellitus with diabetic neuropathic arthropathy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference